Purified anti-human CD28 Antibody
- 产品名称：
- Purified anti-human CD28 Antibody
- 产品类别：
- 抗体
- 产品编号：
- 302901
- 产品应用：
- 302901
- Verified Reactivity
- Human, Cynomolgus, Rhesus
- Reported Reactivity
- Baboon, Capuchin Monkey, Chimpanzee, Pigtailed Macaque, Sooty Mangabey, Squirrel Monkey
- Antibody Type
- Monoclonal
- Host Species
- Mouse
- Formulation
- Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
- Preparation
- The antibody was purified by affinity chromatography.
- Concentration
- 0.5 mg/ml
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C.
- Application
-
FC - Quality tested
IHC-F, Costim, FA - Reported in the literature, not verified in house
- Recommended Usage
Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.5 ?g per 106 cells in 100 ?l volume or 100 ?l whole blood. It is recommended that the reagent be titrated for optimal performance for each application.
- Application Notes
The Ultra-LEAF? Purified antibody (Endotoxin < 0.01 EU/?g, Azide-Free, 0.2 ?m filtered) is recommended for highly sensitive assays.
- Application References
(PubMed link indicates BioLegend citation) -
- Schlossman S, et al. Eds. 1995. Leucocyte Typing V. Oxford University Press. New York.
- Nunes J, et al. 1993. Biochem. J. 293:835.
- Calea-Lauri J, et al. 1999. J. Immunol. 163:62.
- Tazi A, et al. 1999. J. Immunol. 163:3511. (IHC)
- Marti F, et al. 2001. J. Immunol. 166:197. (Costim)
- Jeong SH, et al. 2004. J. Virol. 78:6995. (Costim)
- Rivollier A, et al. 2004. Blood 104:4029. (Costim)
- Scharschmidt E, et al. 2004. Mol. Cell Biol. 24:3860. (Costim)
- Sheng W, et al. 2007.Elsevier 580:6819. PubMed
- Mitsuhashi M. 2007. Clin Chem.53:148. PubMed
- Ye Z, et al. 2008. Infect. Immun. 76:2541. PubMed
- Magatti M, et al. 2008. Stem Cells 26:182. (FA) PubMed
- Yoshino N, et al. 2008. Exp. Anim. (Tokyo) 49:97. (FC)
- Berg M, et al. 2008. J Leukoc Biol. 83:853. (IP) PubMed
- Rout N, et al. 2010. PLoS One 5:e9787. (FC)
- Leonard JA, et al. 2011. J. Virol. 85:6867. PubMed
- Nomura T, et al. 2012. J. Virol. 86:6481. PubMed
- Product Citations
-
- Liu L, et al. 2016. Nat Biotechnol. 10.1038/nbt.3461. PubMed
- Panigrahi S, et al. 2020. PLoS Pathog. e1008885:16. PubMed
- Mousset CM, et al. 2018. Oncoimmunology. 7:e1488565. PubMed
- Mitsuhashi M 2007. Clin Chem. 53:148. PubMed
- Mammadli M, et al. 2021. Clin Transl Med. 11:e625. PubMed
- Friebel E, et al. 2020. Cell. 181(7):1626-1642.e20. PubMed
- Zhang Y, et al. 2019. Cell Res. 29:609. PubMed
- Li G, et al. 2021. Oncoimmunology. 10:1983306. PubMed
- Barzilai S, et al. 2017. Cell Rep. 18(3):685-699. PubMed
- Taft J, et al. 2021. Cell. 184(17):4447-4463.e20. PubMed
- Zhu Y, et al. 2019. Front Genet. 10:141. PubMed
- Ahmed R et al. 2019. Cell. 177(6):1583-1599 . PubMed
- Liang J, et al. 2017. Nat Commun. 8:15732. PubMed
- Zucchetti AE, et al. 2019. Nat Commun. 10:2864. PubMed
- Yang W, et al. 2020. Nat Commun. 3.553472222. PubMed
- Bluhm J, et al. 2018. Mol Ther. 26:1906. PubMed
- Fasbender F, et al. 2017. Front Immunol. 0.88125. PubMed
- Xiao C, et al. 2022. iScience. 25:103934. PubMed
- Tocheva AS, et al. 2020. J Biol Chem. 295:18036. PubMed
- Haas R, et al. 2015. PLoS Biol. 13: 1002202. PubMed
- Bobardt M, et al. 2020. PLoS One. 15:e0227715. PubMed
- Willimsky G, et al. 2021. Elife. 10:. PubMed
- Song C, et al. 2022. Stem Cell Res Ther. 13:48. PubMed
- Peng Q, et al. 2022. EBioMedicine. 77:103904. PubMed
- Nathan A, et al. 2021. Cell. 184(17):4401-4413.e10. PubMed
- Kaufmann M, et al. 2021. Med. 2(3):296-312.e8. PubMed
- Ye Z, et al. 2008. Infect Immun. 76:2541. PubMed
- Woolsey C, et al. 2020. Scientific Reports. 10(1):3071.. PubMed
- Holbrook AK, et al. 2019. Physiol Rep. 7:e14234. PubMed
- Dias J, et al. 2018. Proc Natl Acad Sci U S A. 115:E11513. PubMed
- Oberg HH, et al. 2020. J Leukoc Biol. 107:1081. PubMed
- Gaa R, et al. 2021. MAbs. 13:1978130. PubMed
- Wilson AS, et al. 2022. Nat Commun. 13:528. PubMed
- Kondo H, et al. 2022. Front Immunol. 13:836923. PubMed
- Hu X, et al. 2021. British Journal of Pharmacology. 178(6):1445-1458. PubMed
- Li L, et al. 2020. J Transl Med. 18:363. PubMed
- Meléndez AV, et al. 2022. Cell Mol Life Sci. 79:513. PubMed
- Le X, et al. 2021. J Thorac Oncol. 16:583. PubMed
- Qiu C, et al. 2022. Front Immunol. 12:764949. PubMed
- Guo T, et al. 2018. J Immunol. 200:500. PubMed
- Jin H, et al. 2019. MBio. 10:e01769-19. PubMed
- Jimenez RV, et al. 2019. Front Immunol. 1.932638889. PubMed
- Li H, et al. 2020. Front Immunol. 11:1777. PubMed
- O'Boyle KC, et al. 2020. Methods Mol Biol. 2111:1. PubMed
- Cai J, et al. 2021. eLife. 10:00. PubMed
- Kinosada H, et al. 2017. PLoS Pathog. 10.1371/journal.ppat.1006120. PubMed
- Zhu Y, et al. 2019. Cell Stem Cell. 25:542. PubMed
- Liu Y, et al. 2022. Micromachines (Basel). 13:. PubMed
- Leonard J, et al. 2011. J Virol. 85:6867. PubMed
- Seo N, et al. 2018. Nat Commun. 9:435. PubMed
- Qiu H, et al. 2017. Exp Cell Res.. 10.1016/j.yexcr.2017.08.036. PubMed
- Jakob M, et al. 2020. Cells. 10:. PubMed
- Tocheva AS, et al. 2020. J Biol Chem. 295:18036. PubMed
- Sattler A, et al. 2021. Am J Transplant. 21:87. PubMed
- Jin Y, et al. 2017. Int Immunopharmacol. . 10.1016/j.intimp.2017.10.009. PubMed
- Pardons M, et al. 2019. PLoS Pathog. 15:e1007619. PubMed
- Gee MH, et al. 2018. Cell. 172:549. PubMed
- Wiedeman AE, et al. 2020. J Clin Invest. 130:480. PubMed
- Zavidij O, et al. 2020. Nat Cancer. 0.384027778. PubMed
- Singh AK, et al. 2017. Front Immunol. 0.513888889. PubMed
- Bonavia AS, et al. 2022. Front Immunol. 13:940030. PubMed
- Levin SD, et al. 2020. Front Immunol. 10:3086. PubMed
- Fernández-Orth J, et al. 2020. Eur J Immunol. . PubMed
- Pawlak EN, et al. 2018. Retrovirology. 15:6. PubMed
- Bengsch B et al. 2018. Immunity. 48(5):1029-1045 . PubMed
- Tsai HI, et al. 2021. EMBO Mol Med. 13:e12834. PubMed
- Duque JSR, et al. 2022. Nat Commun. 13:3700. PubMed
- Pan Y, et al. 2021. Br J Pharmacol. 178:4907. PubMed
- Sheng WY, et al. 2006. FEBS Lett. 580:6819. PubMed
- Moosmann C, et al. 2022. STAR Protoc. 3:101031. PubMed
- Cassioli C, et al. 2021. Front Cell Dev Biol. 9:673446. PubMed
- Celis‐Gutierrez J et al. 2019. Cell Rep. 27(11):3315-3330 . PubMed
- Mazer M, et al. 2019. J Immunol. 203:2088. PubMed
- Nomura T, et al. 2012. J Virol. 86:6481. PubMed
- Naranbhai V, et al. 2022. Cell. . PubMed
- Srivastava S, et al. 2020. Cancer Cell. 39(2):193-208.e10. PubMed
- He Y, et al. 2021. eLife. 10:00. PubMed
- Jones N, et al. 2017. Front Immunol. . 10.3389/fimmu.2017.01516. PubMed
- Bantug GR, et al. 2018. Immunity. 48:542. PubMed
- Ren X, et al. 2021. Lab Chip. 21:1527. PubMed
- Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
- Ravell JC, et al. 2020. J Clin Invest. 130:507. PubMed
- Martin E, et al. 2020. JCI Insight. :5. PubMed
- Umeda M, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
- RRID
- AB_314303 (BioLegend Cat. No. 302901) AB_314304 (BioLegend Cat. No. 302902)
- Structure
- Ig superfamily, type I transmembrane glycoprotein, homodimer, 44 kD
- Distribution
-
Mature T cells, thymocytes, NK cell subsets, plasma cells, EBV-positive B cells
- Function
- T cell costimulation
- Ligand/Receptor
- CD80, CD86
- Cell Type
- B cells, NK cells, Plasma cells, T cells, Thymocytes, Tregs
- Biology Area
- Costimulatory Molecules, Immunology
- Molecular Family
- CD Molecules
- Antigen References
-
1. Schlossman S, et al. Eds. 1995. Leucocyte Typing V. Oxford University Press. New York.
2. June CH, et al. 1994. Immunol. Today 15:321.
3. Linskey PS, et al. 1993. Annu. Rev. Immunol. 11:191.
- Gene ID
- 940 View all products for this Gene ID
- UniProt
- View information about CD28 on UniProt.org
